Wilson Troy Edward bought 101,119 shares of Kura Oncology, Inc. at $7.42 for $750k on Nov 16, 2026

Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
President and CEO
President and CEO
Filed Nov 16, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$750,302.98Shares × reported price
Shares traded
101,119Common Stock
Price per share
$7.42Reported price. Read footnotes for ranges.
% of reported position traded
18.92%This security and ownership context
Holdings after
635,456Direct
Trade date
Nov 16, 2026Buy
Filed
Nov 16, 2026, 7:45 PM ET1-day reporting delay
Accession
0001193125-26-464166Code P · Transaction 402271
How reported position traded is calculated

Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 534,337 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 13, 2026Buy98,881$7.63$754,462.03Trade 402270
2 transaction rows in this filing. Joint filers share the same rows.

KURA price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
KURA · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 24, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −14%1w ago 0%1d ago 0%
Returns since7d30d90d180d1y

Footnotes in full

F1: This transaction was executed in multiple trades at prices ranging from $7.47 to $7.79. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2: This transaction was executed in multiple trades at prices ranging from $7.27 to $7.73. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.